Growth Metrics

Tandem Diabetes Care (TNDM) Net Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.11%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4,440.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 84.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 84.38%
Dec 31, 2025 -170.61%
Sep 30, 2025 8.92%
Jun 30, 2025 -70.12%
Mar 31, 2025 -205.54%
Dec 31, 2024 102.56%
Sep 30, 2024 29.44%
Jun 30, 2024 13.69%
Mar 31, 2024 65.51%
Dec 31, 2023 -89.31%
Sep 30, 2023 32.82%
Jun 30, 2023 -137.21%
Mar 31, 2023 -742.67%
Dec 31, 2022 -247.28%
Sep 30, 2022 -951.95%
Jun 30, 2022 -475.50%
Mar 31, 2022 -190.46%
Dec 31, 2021 -36.68%
Sep 30, 2021 161.10%
Jun 30, 2021 113.73%
Mar 31, 2021 65.96%
Dec 31, 2020 541.03%
Sep 30, 2020 -224.30%
Jun 30, 2020 -1,830.89%
Mar 31, 2020 35.33%
Dec 31, 2019 -28.09%
Sep 30, 2019 91.53%
Jun 30, 2019 88.96%
Mar 31, 2019 -49.36%
Dec 31, 2018 138.73%
Sep 30, 2018 -161.29%
Jun 30, 2018 27.56%
Mar 31, 2018 27.27%
Dec 31, 2017 28.44%
Sep 30, 2017 53.82%
Jun 30, 2017 -11.58%
Mar 31, 2017 -10.70%
Dec 31, 2016 -19.56%
Sep 30, 2016 -52.45%
Jun 30, 2016 8.94%
Mar 31, 2016 5.86%
Dec 31, 2015 36.28%
Sep 30, 2015 1.90%
Jun 30, 2015 -1.77%
Mar 31, 2015 2.44%
Dec 31, 2014 -6.15%
Sep 30, 2014 -56.49%
Jun 30, 2014 -33.71%
Mar 31, 2014 -190.49%